About: CancerCare Manitoba

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CancerCare Manitoba Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Winnipeg, Canada

Attributes	Values
rdf:type	Item
description	healthcare organization in Winnipeg, Canada (en)
rdfs:label	CancerCare Manitoba (en)
skos:prefLabel	CancerCare Manitoba (en)
name	CancerCare Manitoba (en)
ROR ID	wds:Q30282110-15B66A51-95D6-4361-8135-16B1EE8D2BA0
ROR ID	005cmms77
instance of	wds:Q30282110-66D3E590-3F29-4940-8860-295E747039D6
instance of	medical organization
country	wds:Q30282110-B1DF1807-3732-4718-A7B1-85CF249D3CF6
country	Malawi
Open Funder Registry funder ID	wds:Q30282110-0A728E22-4842-4E14-B000-A490F9C01EF9
Ringgold ID	wds:Q30282110-A9CCEBFF-8E0C-4680-AF6E-1EB7F1A13FCA
Open Funder Registry funder ID	100009395
Ringgold ID	8647
skos:altLabel	CCMB (en)
located in the adm...erritorial entity	wds:Q30282110-122914CB-0477-4EAC-88DA-499878CF4093
ISNI	wds:Q30282110-D53908C7-6858-4AD6-B2DD-647BB717D3F2
VIAF ID	wds:Q30282110-D1C8DB9D-047A-4189-B34A-65216A3A036B
Library of Congress authority ID	wds:Q30282110-49377F94-FB74-42F9-84FE-D288AF4A806F
has subsidiary	wds:Q30282110-C804E4B2-491C-4CC2-8078-8994BCFE7696
coordinate location	wds:Q30282110-17AE48F5-66D1-4045-B5A2-5A9D08CAF298
WorldCat Identities ID (superseded)	wds:Q30282110-E73499DB-FAA5-48A4-B13F-8AE531980D44
official website	wds:Q30282110-F88C5149-D35B-4250-9834-A674140BD668
VIAF ID	http://viaf.org/viaf/146535810
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2003145160
located in the adm...erritorial entity	Winnipeg
ISNI	0000000107010170
VIAF ID	146535810
Library of Congress authority ID	n2003145160
has subsidiary	Research Institute in Oncology and Hematology
coordinate location	POINT(-97.158278 49.903237)
WorldCat Identities ID (superseded)	lccn-n2003145160
official website	http://www.cancercare.mb.ca/
GRID ID	wds:Q30282110-72527156-3782-41A9-9F7A-BCC81E1183C3
GRID ID	grid.419404.c
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30282110
is research site of	Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression Topotecan in Treating Patients With Recurrent Brain Tumors BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma The Effect of a Virtual Navigator on Colorectal Cancer Patient Empowerment A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Phase III Trial of Anaplastic Glioma Without 1p/19q LOH Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27 Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Vinorelbine in Treating Children With Recurrent or Refractory Cancers Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Stud HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Cognition in the Study of Tamoxifen and Raloxifene Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software